Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy

References

• Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther 2010; 11:1811-23; http://dx.doi.org/10.1586/era.10.170
   Web of Science ®Google Scholar
• Madhunapantula SV, Robertson GP. Chemoprevention of melanoma. Adv Pharmacol 2012; 65:361-98; PMID:22959032; http://dx.doi.org/10.1016/B978-0-12-397927-8.00012-9
   PubMedGoogle Scholar
• Inamdar GS, Madhunapantula SV, Robertson GP. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochem Pharmacol 2010; 5:624-37; http://dx.doi.org/10.1016/j.bcp.2010.04.029
   Web of Science ®Google Scholar
• Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 4:274-84; http://dx.doi.org/10.1038/nrc2622
   Web of Science ®Google Scholar
• Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and −9 during early human wound healing. Lab Invest 1994; 2:176-82.
   Google Scholar
• Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998; 16:3743-50.
   Google Scholar
• Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 1997; 17:3201-10; PMID:9413149
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 3:161-74; http://dx.doi.org/10.1038/nrc745
   Web of Science ®Google Scholar
• Gong Y, Chippada-Venkata UD, Oh WK. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel) 2014; 3:1298-327; http://dx.doi.org/10.3390/cancers6031298
   Web of Science ®Google Scholar
• Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 1:19-26; http://dx.doi.org/10.1002/jcp.20948
   Web of Science ®Google Scholar
• Sun J. Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells. J Signal Transduct 2010; 2010:985132; PMID:21152266; http://dx.doi.org/10.1155/2010/985132
   PubMedGoogle Scholar
• Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000; 4:252-7; http://dx.doi.org/10.1186/bcr65
   Web of Science ®Google Scholar
• Hanemaaijer R, Verheijen JH, Maguire TM, Visser H, Toet K, McDermott E, O'Higgins N, Duffy MJ. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 2000; 2:204-7; http://dx.doi.org/10.1002/(SICI)1097-0215(20000415)86:2%3c204::AID-IJC9%3e3.0.CO;2-6
   Web of Science ®Google Scholar
• Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 17:1260-70; http://dx.doi.org/10.1093/jnci/89.17.1260
   Web of Science ®Google Scholar
• Davies KJ. The Complex Interaction of Matrix Metalloproteinases in the Migration of Cancer Cells through Breast Tissue Stroma. Int J Breast Cancer 2014; 2014:839094; PMID:24800085
   PubMedGoogle Scholar
• Määttä M, Soini Y, Liakka A, Autio-Harmainen H. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res 2000; 7:2726-2734.
   Google Scholar
• Said AH, Raufman JP, Xie G. The role of matrix metalloproteinases in colorectal cancer. Cancers (Basel) 2014; 6:366-375; PMID:24518611; http://dx.doi.org/10.3390/cancers6010366
   PubMed Web of Science ®Google Scholar
• Vaday GG, Schor H, Rahat, MA, Lahat N, Lider O. Transforming growth factor-β suppresses tumor necrosis factor α-induced matrix metalloproteinase-9 expression in monocytes. J Leukoc Biol 2001; 4:613-621.
   Google Scholar
• Aalinkeel R, Nair MP, Sufrin G, Mahajan SD, Chadha KC, Chawda RP, Schwartz SA. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res 2004; 15:5311-21; http://dx.doi.org/10.1158/0008-5472.CAN-2506-2
   Web of Science ®Google Scholar
• Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 2004; 22:7621-8; http://dx.doi.org/10.1158/1078-0432.CCR-04-1061
   Web of Science ®Google Scholar
• Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 2001; 15:1953-62; PMID:11532975; http://dx.doi.org/10.1096/fj.01-0198com
   PubMed Web of Science ®Google Scholar
• Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and −9 in human fibrosarcoma HT-1080 cells. Cancer Res 2002; 62:1025-9; PMID:11861377
   PubMed Web of Science ®Google Scholar
• Shin Y, Yoon SH, Choe EY, Cho SH, Woo CH, Rho JY, Kim JH. PMA-induced upregulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol Med 2007; 39:97-105; PMID:17334233; http://dx.doi.org/10.1038/emm.2007.11
   PubMed Web of Science ®Google Scholar
• Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J. Amplification of IL- 1 β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 2000; 165:5788-97; PMID:11067938; http://dx.doi.org/10.4049/jimmunol.165.10.5788
   PubMed Web of Science ®Google Scholar
• Garg A, Aggarwal BB. Nuclear transcription factor-kB as a target for cancer drug development. Leukemia 2002; 16:1053-68; PMID:12040437; http://dx.doi.org/10.1038/sj.leu.2402482
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, Girolomoni G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005; 174:5047-56; PMID:15814736; http://dx.doi.org/10.4049/jimmunol.174.8.5047
   PubMed Web of Science ®Google Scholar
• Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998; 2:466-71; PMID:9736919; http://dx.doi.org/10.1016/S1367-5931(98)80122-1
   PubMed Web of Science ®Google Scholar
• Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56:190-6; PMID:8548762
   PubMed Web of Science ®Google Scholar
• Pandey RK, Dahiya Y, Sodhi A. Mycobacterium indicus pranii downregulates MMP-9 and iNOS through COX-2 dependent and TNF-α independent pathway in mouse peritoneal macrophages in vitro. Microbes Infect 2012; 4:348-56; http://dx.doi.org/10.1016/j.micinf.2011.11.004
   Web of Science ®Google Scholar
• Gupta A, Geetha N, Mani J, Upadhyay P, Katoch VM, Natrajan M, Gupta UD, Bhaskar S. Immunogenicity and protective efficacy of “Mycobacterium w” against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M.w by the aerosol or parenteral route. Infect Immun 2009; 1:223-31; http://dx.doi.org/10.1128/IAI.00526-08
   Web of Science ®Google Scholar
• Rakshit S, Ponnusamy M, Papanna S, Saha B, Ahmed A, Nandi D. Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNγ. Int J Cancer 2012; 4:865-75; http://dx.doi.org/10.1002/ijc.26099
   Web of Science ®Google Scholar
• Ahmad F, Man J, Kumar P, Haridas S, Upadhyay P, Bhaskar S. Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice. PLoS One 2011; 9:e25424; http://dx.doi.org/10.1371/journal.pone.0025424
   Web of Science ®Google Scholar
• Adhikari A, Majumder S, Banerjee S, Gupta G, Bhattacharya P, Majumdar SB, Saha B, Majumdar S. Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling. J Antimicrob Chemother 2012; 12:2892-2902; http://dx.doi.org/10.1093/jac/dks315
   Web of Science ®Google Scholar
• Kumar P, Tyagi R, Das G, Bhaskar S. Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner. Immunology 2014; 143:258-68; PMID:24766519; http://dx.doi.org/10.1111/imm.12306
   PubMed Web of Science ®Google Scholar
• Adhikari A, Gupta G, Majumder S, Banerjee S, Bhattacharjee S, Bhattacharya P, Kumari S, Haldar S, Majumdar SB, Saha B, Majumdar S. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12. PLoS One 2012; 7:e40265; PMID:22792256; http://dx.doi.org/10.1371/journal.pone.0040265
   PubMed Web of Science ®Google Scholar
• Purcell WT, Rudek MA, Hidalgo M. Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol Oncol Clin North Am 2002; 5:1189-227; http://dx.doi.org/10.1016/S0889-8588(02)00044-8
   Web of Science ®Google Scholar
• Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996; 22:5279-84.
   Google Scholar
• Hwang YP, Yun HJ, Kim HG, Han EH, Lee GW, Jeong HG. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms. Biochem Pharmacol 2010; 12:1714-26; http://dx.doi.org/10.1016/j.bcp.2010.02.003
   Web of Science ®Google Scholar
• Halder K, Banerjee S, Bose A, Majumder S, Majumdar S. Overexpressed PKCδ downregulates the expression of PKCα in B16F10 melanoma: induction of apoptosis by PKCδ via ceramide generation. PLoS One 2014; 3:e91656; http://dx.doi.org/10.1371/journal.pone.0091656
   Web of Science ®Google Scholar
• Tahara E, Kadara H, Lacroix L, Lotan D, Lotan R. Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction. Cancer Biol Ther 2009; 9:801-7; http://dx.doi.org/10.4161/cbt.8.9.8186
   Web of Science ®Google Scholar
• Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 1999; 22:15407-14; http://dx.doi.org/10.1074/jbc.274.22.15407
   Web of Science ®Google Scholar
• Song G, Ouyang G, Mao Y, Ming Y, Bao S, Hu T. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1α upregulation and MMP9 activation. J Cell Mol Med 2008; 13:1706-18; http://dx.doi.org/10.1111/j.1582-4934.2008.00540.x
   Web of Science ®Google Scholar
• Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265:13933-8; PMID:2380196
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265:13933-8; PMID:2380196
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity. Annu Rev Immunol 2000; 18:621-63; PMID:10837071; http://dx.doi.org/10.1146/annurev.immunol.18.1.621
   PubMed Web of Science ®Google Scholar
• Karin M, Liu Zg, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 2:240-6; http://dx.doi.org/10.1016/S0955-0674(97)80068-3
   Web of Science ®Google Scholar
• Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, Lee YH, Park JW, Kwon TK. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.Oncogene 2004; 23:1845-53; PMID:14661062; http://dx.doi.org/10.1038/sj.onc.1207307
   PubMed Web of Science ®Google Scholar
• Hsiang CY, Wu SL, Chen JC, Lo HY, Li CC, Chiang SY, Wu HC, Ho TY. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicol Lett 2007; 171:78-86; PMID:17543481; http://dx.doi.org/10.1016/j.toxlet.2007.04.009
   PubMed Web of Science ®Google Scholar
• Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 2009; 7:1225-33; http://dx.doi.org/10.1093/carcin/bgp111
   Web of Science ®Google Scholar
• Guyonneau L, Murisier F, Rossier A, Moulin A, Beermann F. Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice. Mol Cell Biol 2004; 24:3396-403.
   PubMed Web of Science ®Google Scholar
  Karin M, Liu Zg, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 2:240-6; http://dx.doi.org/10.1128/MCB.24.8.3396-3403.2004
   Web of Science ®Google Scholar
• Chomezynasky P, Sacchi N. A single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9; PMID:2440339; http://dx.doi.org/10.1006/abio.1987.9999
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. NewYork: Cold Spring Harbor, Cold Spring Laboratory Press. 1989.
   Google Scholar
  Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 2009; 7:1225-33.
   Web of Science ®Google Scholar
• Majumdar S, Kane LH, Rossi MW, Volpp BD, Nauseef WM, Korchak HM. Protein kinase C isotypes and signal transduction in human neutrophils: selective substrate specificity of calcium dependent β-PKC and novel calcium independent n-PKC. Biochim Biophys Acta 1993; 1176:276-86; PMID:8471629; http://dx.doi.org/10.1016/0167-4889(93)90056-U
   PubMed Web of Science ®Google Scholar
• Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S. Leishmania donovani suppresses activator protein-1 and NF-kB in host macrophages via ceramide generation: involvement of extracellular signal regulated kinase. Infect Immun 2002; 70:6828-38; PMID:12438359; http://dx.doi.org/10.1128/IAI.70.12.6828-6838.2002
   PubMed Web of Science ®Google Scholar
• Das S, Banerjee S, Majumder S, Paul Chowdhury B, Goswami A, Halder K, Chakraborty U, Pal NK, Majumdar S. Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10. PLoS One 2014; 4:e92477; http://dx.doi.org/10.1371/journal.pone.0092477
   Web of Science ®Google Scholar